Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sézary Syndrome

Case series (n=19) found mogamulizumab-associated rash had a heterogeneous clinical presentation with variable and delayed onset in these patients; it exhibited a predilection for the head and neck and was difficult to clinically distinguish from relapse or disease progression.

Source:

JAMA Dermatology